Bank of New York Mellon’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Sell |
|
|||||
|
2025
Q1 | $607K | Sell |
|
|||||
|
2024
Q4 | $710K | Sell |
|
|||||
|
2024
Q3 | $713K | Sell |
|
|||||
|
2024
Q2 | $881K | Buy |
|
|||||
|
2024
Q1 | $968K | Sell |
|
|||||
|
2023
Q4 | $779K | Sell |
|
|||||
|
2023
Q3 | $964K | Buy |
|
|||||
|
2023
Q2 | $1.2M | Buy |
|
|||||
|
2023
Q1 | $1.04M | Sell |
|
|||||
|
2022
Q4 | $1.54M | Buy |
|
|||||
|
2022
Q3 | $1.75M | Buy |
|
|||||
|
2022
Q2 | $1.92M | Sell |
|
|||||
|
2022
Q1 | $2M | Sell |
|
|||||
|
2021
Q4 | $2.48M | Buy |
|
|||||
|
2021
Q3 | $9.09M | Buy |
|
|||||
|
2021
Q2 | $4.22M | Buy |
|
|||||
|
2021
Q1 | $2.73M | Buy |
|
|||||
|
2020
Q4 | $1.54M | Buy |
|